EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The ins and outs of innate and adaptive type 2 immunity

Ari B Molofsky, Richard M Locksley

Immunity · 2023-04 · 56 (4) · 704-722

DOI: 10.1016/j.immuni.2023.03.014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunity, 2023-04. Verfasst von Ari B Molofsky und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lab Medicine, University of California, San Francisco, San Francisco, CA 94143-0451, USA. Hauptthemen laut MEDLINE: Immunity, Innate, Hypersensitivity. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, Howard Hughes Medical Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 immunity is orchestrated by a canonical group of cytokines primarily produced by innate lymphoid cells, group 2, and their adaptive counterparts, CD4+ helper type 2 cells, and elaborated by myeloid cells and antibodies that accumulate in response. Here, we review the cytokine and cellular circuits that mediate type 2 immunity. Building from insights in cytokine evolution, we propose that innate type 2 immunity evolved to monitor the status of microbe-rich epithelial barriers (outside) and sterile parenchymal borders (inside) to meet the functional demands of local tissue, and, when necessary, to relay information to the adaptive immune system to reinforce demarcating borders to sustain these efforts. Allergic pathology likely results from deviations in local sustaining units caused by alterations imposed by environmental effects during postnatal developmental windows and exacerbated by mutations that increase vulnerabilities. This framework positions T2 immunity as central to sustaining tissue repair and regeneration and provides a context toward understanding allergic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateHypersensitivityHumansLymphocytesAdaptive ImmunityCytokines

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Lab Medicine, University of California, San Francisco, San Francisco, CA 94143-0451, USA.
  • Howard Hughes Medical Institute and Department of Medicine, University of California, San Francisco, San Francisco, CA 94143-0795, USA. Electronic address: richard.locksley@ucsf.edu.

Förderung

  • NHLBI NIH HHS
  • NIAID NIH HHS
  • Howard Hughes Medical Institute
  • NINDS NIH HHS

Zitieren

APA

Molofsky, A. B., & Locksley, R. M. (2023). The ins and outs of innate and adaptive type 2 immunity. Immunity, 56(4), 704-722. https://doi.org/10.1016/j.immuni.2023.03.014

Vancouver

Molofsky AB, Locksley RM. The ins and outs of innate and adaptive type 2 immunity. Immunity. 2023;56(4):704-722. doi:10.1016/j.immuni.2023.03.014

BibTeX
@article{Molofsky2023,
  author = {Molofsky, Ari B and Locksley, Richard M},
  title = {The ins and outs of innate and adaptive type 2 immunity},
  journal = {Immunity},
  year = {2023},
  volume = {56},
  number = {4},
  pages = {704--722},
  doi = {10.1016/j.immuni.2023.03.014}
}
Kostenlos starten →